Cabometyx and Herniated nucleus pulposus (slipped disk) - a phase IV clinical study of FDA data

Summary:

Herniated nucleus pulposus (slipped disk) is reported only by a few people who take Cabometyx.

The phase IV clinical study analyzes which people take Cabometyx and have Herniated nucleus pulposus (slipped disk). It is created by eHealthMe based on reports of 22,318 people who have side effects while taking Cabometyx from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 26, 2022

22,318 people reported to have side effects when taking Cabometyx.
Among them, 2 people (0.01%) have Herniated nucleus pulposus (slipped disk).

What is Cabometyx?

Cabometyx has active ingredients of cabozantinib s-malate. eHealthMe is studying from 22,320 Cabometyx users for its effectiveness, alternative drugs and more.

What is Herniated nucleus pulposus (slipped disk)?

Herniated nucleus pulposus (slipped disk) is found to be associated with 1,342 drugs and 752 conditions by eHealthMe.

Number of Cabometyx and Herniated nucleus pulposus (slipped disk) reports submitted per year:

Could Cabometyx cause Herniated nucleus pulposus (slipped disk)?

Gender of people who have Herniated nucleus pulposus (slipped disk) when taking Cabometyx *:

female: 0.0 %
male: 100 %

Age of people who have Herniated nucleus pulposus (slipped disk) when taking Cabometyx *:

Common drugs people take besides Cabometyx *:

Ranitidine: 1 person, 50.00%
Lorazepam: 1 person, 50.00%
Ezetimibe: 1 person, 50.00%
Amlodipine: 1 person, 50.00%

Common side effects people have besides Herniated nucleus pulposus (slipped disk) *:

Skin Ulcer: 1 person, 50.00%
Muscle Spasms (muscle contraction): 1 person, 50.00%
Mucosal Inflammation (infection of mucous membrane): 1 person, 50.00%
Lower Respiratory Tract Infection: 1 person, 50.00%
Indigestion: 1 person, 50.00%
Fatigue (feeling of tiredness): 1 person, 50.00%
Blood Potassium Decreased: 1 person, 50.00%
Blood Magnesium Decreased: 1 person, 50.00%

Common conditions people have *:

Renal Cell Carcinoma (a kidney cancer): 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cabometyx and have Herniated nucleus pulposus (slipped disk)?

Check whether Herniated nucleus pulposus (slipped disk) is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Herniated nucleus pulposus (slipped disk) and when was it recovered:

Herniated nucleus pulposus (slipped disk) in Cabometyx

Expand to all the drugs that have ingredients of cabozantinib s-malate:

Herniated nucleus pulposus (slipped disk) and drugs with ingredients of cabozantinib s-malate

Alternative drugs to, pros and cons of Cabometyx:

Cabometyx (22,320 reports)

Common Cabometyx side effects:

Browse all side effects of Cabometyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Herniated nucleus pulposus (slipped disk) treatments and more:

Herniated nucleus pulposus (slipped disk) (5,242 reports)

COVID vaccines that are related to Herniated nucleus pulposus (slipped disk):

Common drugs associated with Herniated nucleus pulposus (slipped disk):

All the drugs that are associated with Herniated nucleus pulposus (slipped disk):

Herniated nucleus pulposus (slipped disk) (1,342 drugs)

Common conditions associated with Herniated nucleus pulposus (slipped disk):

Osteoporosis: 659 reports
Pain: 218 reports
Multiple sclerosis: 205 reports
Rheumatoid arthritis: 171 reports
High blood pressure: 158 reports
Gastroesophageal reflux disease: 116 reports
Depression: 105 reports
Back pain: 104 reports

All the conditions that are associated with Herniated nucleus pulposus (slipped disk):

Herniated nucleus pulposus (slipped disk) (752 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cabozantinib s-malate (the active ingredients of Cabometyx) and Cabometyx (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.